Skip to main content
Search

AstraZeneca enters catalyst-rich period with investment paying off

Date: 06 November 2025

1 minute read

6 November 2025

If you are covering AstraZeneca’s latest financial results, please find below a comment from Sheena Berry, healthcare analyst at Quilter Cheviot:

“AstraZeneca posted another strong quarter, with product revenue up 11% and oncology continuing to drive performance, growing 18% on the back of key medicines such as Imfinzi, Tagrisso and Enhertu.

“The company is investing heavily in future growth, with R&D spend up 14% as it accelerates clinical trial recruitment and advances its pipeline. In the US, where AstraZeneca generates over 40% of its sales, revenues rose 9%. AstraZeneca is one of two pharmaceutical companies to have established an agreement with the US Government to lower the cost of medicines for American patients and has made a $50bn investment commitment into US manufacturing and R&D.

“Full-year guidance remains unchanged, with sales expected to rise by high single digits and core earnings by low double digits. With multiple positive Phase III readouts and drug approvals this year, AstraZeneca is entering a catalyst-rich period and remains on track toward its ambitious $80bn revenue target by 2030.”

Gregor Davidson

Senior External Communications Manager
+44 (0)7917 522784

Notes to Editors

Notes to Editors:

About Quilter plc

Quilter plc is a leading wealth management business, helping to create brighter financial futures for every generation.

Quilter plc oversees £157.4 billion in customer investments (as at 30 June 2026).

It has an adviser and customer offering spanning financial advice, investment platforms, multi-asset investment solutions and discretionary fund management.

The business is comprised of two branded segments: Quilter and Quilter Cheviot.

Quilter encompasses the financial advice network and national, Quilter's investment platform and multi-asset solutions and Quilter Invest, the digital savings and investment app.

Quilter Cheviot is a discretionary fund management and financial planning business.

This press release is for journalists only and should not be relied upon by financial advisers or customers.

Please remember that past performance is not a guide to future performance. The value of investments and the income from them can go down as well as up and investors may not get back any of the amount originally invested. Exchange rate changes may cause the value of overseas investments to rise or fall.

This communication is issued by Quilter plc.  Registered office: Senator House, 85 Queen Victoria Street, London, EC4V 4AB, United Kingdom. Registered number: 6404270.  Registered in England.

PRIVACY INFORMATION
We hold your name, email address, job role and the name of your publication on our Press Distribution List and use this information to send you press releases which we believe will be of interest to you. You can stop receiving emails from us at any time by emailing us at: pressoffice@quilter.com and asking us to remove you from the Distribution List.

Related Articles

BP agrees to sell majority stake in Castrol to pay down debt

2 minute read

If you are covering the news that BP will sell its majority stake in Castrol to Stonepeak, please see the following comment from Maurizio Carulli, global energy and materials analyst at Quilter Cheviot:

Published 24 December 2025

US inflation comes in cooler than expected as focus on Fed independence grows

1 minute read

If you are covering the latest US inflation data, please see the following comment from Richard Carter, head of fixed interest research at Quilter Cheviot:

Published 18 December 2025